244 related articles for article (PubMed ID: 27879958)
1. Six-year multicenter experience of standard endovascular treatment of critical limb ischemia in the era of drug-eluting devices.
Brizzi V; Caradu C; Berard X; Sassoust G; Midy D; Ducasse E
J Cardiovasc Surg (Torino); 2018 Oct; 59(5):707-715. PubMed ID: 27879958
[TBL] [Abstract][Full Text] [Related]
2. Primary Self-EXPANDing Nitinol Stenting vs Balloon Angioplasty With Optional Bailout Stenting for the Treatment of Infrapopliteal Artery Disease in Patients With Severe Intermittent Claudication or Critical Limb Ischemia (EXPAND Study).
Schulte KL; Pilger E; Schellong S; Tan KT; Baumann F; Langhoff R; Torsello G; Zeller T; Amendt K; Brodmann M;
J Endovasc Ther; 2015 Oct; 22(5):690-7. PubMed ID: 26245919
[TBL] [Abstract][Full Text] [Related]
3. Sense and nonsense of bare metal stents below the knee.
Caradu C; Brizzi V; Auque H; Midy D; Ducasse E
J Cardiovasc Surg (Torino); 2016 Oct; 57(5):653-66. PubMed ID: 27177357
[TBL] [Abstract][Full Text] [Related]
4. Everolimus-Eluting Stent for Patients With Critical Limb Ischemia and Infrapopliteal Arterial Occlusive Disease.
Giaquinta A; Vincenzo A; De Marco E; Veroux M; Veroux P
Vasc Endovascular Surg; 2017 Feb; 51(2):60-66. PubMed ID: 28100126
[TBL] [Abstract][Full Text] [Related]
5. Amputation-free Survival in Patients with Critical Limb Ischemia Treated with Paclitaxel-eluting Stents and Paclitaxel-coated Balloons.
Phair J; Carnevale M; Lipsitz EC; Shariff S; Scher L; Garg K
Ann Vasc Surg; 2020 Jan; 62():8-14. PubMed ID: 31207400
[TBL] [Abstract][Full Text] [Related]
6. One-Year Outcomes of the Paclitaxel-Eluting, Self-Expanding Stentys Stent System in the Treatment of Infrapopliteal Lesions in Patients With Critical Limb Ischemia.
Bosiers M; Callaert J; Keirse K; Hendriks JMH; Peeters P; Verbist J; Maene L; Beelen R; Deloose K
J Endovasc Ther; 2017 Jun; 24(3):311-316. PubMed ID: 28351310
[TBL] [Abstract][Full Text] [Related]
7. Primary everolimus-eluting stenting versus balloon angioplasty with bailout bare metal stenting of long infrapopliteal lesions for treatment of critical limb ischemia.
Karnabatidis D; Spiliopoulos S; Diamantopoulos A; Katsanos K; Kagadis GC; Kakkos S; Siablis D
J Endovasc Ther; 2011 Feb; 18(1):1-12. PubMed ID: 21314342
[TBL] [Abstract][Full Text] [Related]
8. Superficial femoral artery TASC D Registry: twelve-month effectiveness analysis of the Pulsar-18 SE nitinol stent in patients with critical limb ischemia.
Lichtenberg M; Stahlhoff W; Boese D
J Cardiovasc Surg (Torino); 2013 Aug; 54(4):433-9. PubMed ID: 24013531
[TBL] [Abstract][Full Text] [Related]
9. Major adverse limb events and wound healing following infrapopliteal artery stent implantation in patients with critical limb ischemia: the XCELL trial.
Rocha-Singh KJ; Jaff M; Joye J; Laird J; Ansel G; Schneider P;
Catheter Cardiovasc Interv; 2012 Nov; 80(6):1042-51. PubMed ID: 22605682
[TBL] [Abstract][Full Text] [Related]
10. Treatment of infrapopliteal post-PTA dissection with tack implants: 12-month results from the TOBA-BTK study.
Brodmann M; Wissgott C; Holden A; Staffa R; Zeller T; Vasudevan T; Schneider P
Catheter Cardiovasc Interv; 2018 Jul; 92(1):96-105. PubMed ID: 29573541
[TBL] [Abstract][Full Text] [Related]
11. BAlloon versus Stenting in severe Ischaemia of the Leg-3 (BASIL-3): study protocol for a randomised controlled trial.
Hunt BD; Popplewell MA; Davies H; Meecham L; Jarrett H; Bate G; Grant M; Patel S; Hewitt C; Andronis L; Deeks JJ; Bradbury A;
Trials; 2017 May; 18(1):224. PubMed ID: 28526046
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcomes following primary drug-eluting stenting of infrapopliteal bifurcations.
Spiliopoulos S; Fragkos G; Katsanos K; Diamantopoulos A; Karnabatidis D; Siablis D
J Endovasc Ther; 2012 Dec; 19(6):788-96. PubMed ID: 23210878
[TBL] [Abstract][Full Text] [Related]
13. Drug-eluting balloon in peripheral intervention for the superficial femoral artery: the DEBATE-SFA randomized trial (drug eluting balloon in peripheral intervention for the superficial femoral artery).
Liistro F; Grotti S; Porto I; Angioli P; Ricci L; Ducci K; Falsini G; Ventoruzzo G; Turini F; Bellandi G; Bolognese L
JACC Cardiovasc Interv; 2013 Dec; 6(12):1295-302. PubMed ID: 24239203
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Follow-up of the PADI Trial: Percutaneous Transluminal Angioplasty Versus Drug-Eluting Stents for Infrapopliteal Lesions in Critical Limb Ischemia.
Spreen MI; Martens JM; Knippenberg B; van Dijk LC; de Vries JPM; Vos JA; de Borst GJ; Vonken EPA; Bijlstra OD; Wever JJ; Statius van Eps RG; Mali WPTM; van Overhagen H
J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28411244
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of Drug-Coated Balloon Angioplasty vs. Conventional Balloon Angioplasty for Endovascular Treatment of Common Femoral Artery Atherosclerotic Disease.
Cantu D; Jawaid O; Kokkinidis D; Giannopoulos S; Valle JA; Waldo SW; Singh GD; Armstrong EJ
Cardiovasc Revasc Med; 2020 Jul; 21(7):867-874. PubMed ID: 31761636
[TBL] [Abstract][Full Text] [Related]
16. Outcome of a drug-eluting stent in longer below-the-knee lesions in patients with critical limb ischemia.
Bosiers MJ; Deloose K; Peeters P; Torsello G; Zeller T; Scheinert D; Schmidt A; Maene L; Keirse K; Varcoe R; Bosiers M
J Cardiovasc Surg (Torino); 2017 Feb; 58(1):49-54. PubMed ID: 27455888
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of combined superficial femoral artery endovascular therapy with popliteal-to-distal bypass: A paradigm shift in surgical open bypass for chronic limb-threatening ischemia.
Kobayashi T; Hamamoto M; Okazaki T; Hasegawa M; Fujiwara T; Takahashi S
Vascular; 2021 Dec; 29(6):905-912. PubMed ID: 33349196
[TBL] [Abstract][Full Text] [Related]
18. Costs of Real-Life Endovascular Treatment of Critical Limb Ischemia: Report from Poland-A European Union Country with a Low-Budget Health Care System.
Krzanowski M; Drelicharz L; Belowski A; Partyka L; Sumek-Brandys B; Ramakrishnan PK; Nizankowski R
Ann Vasc Surg; 2016 Feb; 31():111-23. PubMed ID: 26616505
[TBL] [Abstract][Full Text] [Related]
19. Evidence for the use of drug eluting stents in below-the-knee lesions.
Trombert D; Caradu C; Brizzi V; Bérard X; Midy D; Ducasse E
J Cardiovasc Surg (Torino); 2015 Feb; 56(1):67-71. PubMed ID: 25428562
[TBL] [Abstract][Full Text] [Related]
20. Results of primary stent therapy for femoropopliteal peripheral arterial disease at 7 years.
Stavroulakis K; Torsello G; Manal A; Schwindt A; Hericks C; Stachmann A; Schönefeld E; Bisdas T
J Vasc Surg; 2016 Dec; 64(6):1696-1702. PubMed ID: 27575816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
